Clinical trial applications via Eudralink

Updated 09 April 2021

The Danish Medicines Agency prefers to receive clinical trial applications electronically. For example, applicants can submit the application online via Eudralink or by e-mail to our clinical trial inbox. These options are explained below.

Formats required for Eudralink submission

Use the following formats if you apply via Eudralink:

  • Documents to be included in one PDF file. The file must contain bookmarks for each document included.
  • The maximum file size is 200 MB. If the application is bigger, the IMPD/IB should be included in a separate file.
  • EudraCT XML file.

Application via Eudralink

If you chose to send the documentation via Eudralink, please send it to our email address without password - filling in the subject heading with the name of the sponsor, name of medicinal product and background for the approach.

Eudralink is the European Medicines Agency's (EMA's) system for secure file transfer. To be set up in the system, please send an email to the Eudralink email address, stating in the email that you wish to have a Eudralink account. You will subsequently receive a form that you must fill in and submit. Connection to the system is usually established within a few hours.

Documents that can be submitted

In practice, all documents regarding clinical trials are reviewed by the Clinical Trials Department at the Danish Medicines Agency, and the possibility for submission online via Eudralink concerns the following documents:

  • Applications for clinical trials of medicines in humans and animals
  • Applications for amendment of a clinical trial
  • Annual safety reports (ASR, DSUR)
  • End of Trial notification
  • Final clinical study report as well as publications
  • Notifications in general.